Invention Grant
- Patent Title: Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamate
-
Application No.: US16119671Application Date: 2018-08-31
-
Publication No.: US10662188B2Publication Date: 2020-05-26
- Inventor: Birgit Keil , Franz-Josef Mais , Winfried Joentgen , Alfons Grunenberg
- Applicant: Adverio Pharma GmbH
- Applicant Address: DE Schoenefeld
- Assignee: ADVERIO PHARMA GmbH
- Current Assignee: ADVERIO PHARMA GmbH
- Current Assignee Address: DE Schoenefeld
- Agency: Quarles & Brady LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@57d9434c com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6e592323
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/519
![Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamate](/abs-image/US/2020/05/26/US10662188B2/abs.jpg.150x150.jpg)
Abstract:
This present invention relates to forms of methyl {4.6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3.4-b]pyridino-3-yl]pyrimidino-5-yl}methylcarbamate comprising its Modification I. Modification II. mono-DMSO solvate. sesqui-DMSO solvate and ¼-ethyl acetate solvate.
Public/Granted literature
Information query